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BONE AND BONE DISEASE
A SYMPOSIUM on "Bone and Bone Disease" was held in the Medical Biology
Centre (Q.U.B.) on Friday, 14th February, 1975, under the joint auspices of the
Royal College of Physicians of Edinburgh, the Northern Ireland Council for Post-
graduate Medical Education, and the Ulster Medical Society. The Symposium
proved extremely popular and was attended by over two hundred doctors. The
large attendance was commented upon by Dr. R. F. Robertson (Vice-president of
the Royal College of Physicians of Edinburgh) who opened the symposium. He
remarked that the occasion was unique in that it was the first time the Edinburgh
College had "crossed a sea" to participate in a symposium.
The programme was divided into three sessions: Session 1 was chaired by Pro-
fessor J. J. Pritchard (Department of Anatomy, Q.U.B.), Session 2 by Dr. R. F.
Robertson (Royal College of Physicians of Edinburgh), and Session 3 by Professor
R. H. Girdwood (Department of Medicine, Edinburgh University). The culmination
of the symposium was the annual Sir Thomas and Lady Edith Dixon Lecture,
delivered by Professor H. F. DeLuca (Chairman of the Department of Biochemistry,
University of Wisconsin, Madison), who gave an erudite and enlightening expos-
ition of the present state of knowledge of the metabolism of Vitamin D. For the
lecture the chair was taken by Professor J. E. Morison (President of the Ulster
Medical Society).
The following are abstracts of the papers presented. After each session relevant
points from the discussion are given.
SESSION 1
A. THE CLASSIFICATION OF METABOLIC BONE DISEASE (RICKETS AND
OSTEOMALACIA)
Professor C E. DENT, F.R.S., Ph.D,, M.D., F.R.C.P. (Lond.)
Department of Human Metabolism, University Colkge Hospital Medical School,
London
The discovery in 1919 that rickets was due to a dietary deficiency led to important
improvements in bone disease classification. The superficially similar chondrodys-
trophies could be adequately distinguished. Classical rickets, healing readily with a
few hundred units of vitamin D daily, could be distinguished from the metabolic
forms requiring about 100 times more vitamin D, sometimes with other drugs too.
Progress in the next 10 years comprised the first classic descriptions of coeliac and
renal rickets and then soon after the extension of the latter into three types, "Vita-
min D resistant" rickets, renal tubular acidosis and the Fanconi syndrome (in which
renal tubular rather than glomerular dysfunction occurs). After this still further
subdivisions of these types occurred and in addition quite new causes were and are
132still being found. There are now over 30 different types of metabolic rickets, of such
diverse origins as phosphate lack from overdosage with aluminium hydroxide,
heavy metal poisoning of the renal tubule, as part of the bone disease in primary
hyperparathyroidism, from various hereditary renal tubular syndromes, varieties of
malabsorption syndromes and perhaps most interesting of all theoretically, from an
obscure chemical complication clearly attributable to certain tumours of bone and
soft tissue.
B. INVESTIGATIVE APPROACH TO BONE DISEASE
Professor D. L. GARDNER, M.D., F.R4CP. (Edi6.), F.R.CPath., M.IR.GP. (Lond.)
Professor of Pathology and Director of the Intitute of Pathology,
The Queen's University of Belfast
A full understanding of the nature of a generalised disease of bone often comes
only from the use of a wide variety of diagnostic laboratory procedures. Among the
most valuable is iliac crest bone biopsy. A cylindrical specimen of dense cortical
and of cancellous iliac bone is obtained by a motor driven trephine. The material,
which is suitable for x-ray, for microincineration, for scanning-and for direct
electron microscopy, is divided longitudinally. This gives (1) a block decalcified in
EDTA or in a formic acid/sodium citrate mixture and used to prepare paraffin
sections that establish the presence or absence of neoplastic and haemopoietic
diseases; and (2) a block embedded in epon wax or araldite to give undecalcified
sections. Alternatively, one of the two blocks may be rapidly frozen and used to
prepare undecalcified sections at low temperature in a bone cryostat.
Undecalcified sections enable the recognition of the extent of osteoid seams and
the diagnosis of the osteomalacic syndromes. The survey of sections from bone in
which tetracycline has been incorporated during life as a measure of bone growth is
facilitated. Cryostat sections can be used for enzyme histochemistry, in the diagnosis,
for example, of hypophosphatasia.
Important systematic studies of bone disease by these and other techniques have
been made by Frost. This survey concluded by illustrating the microscopic appear-
ances of some of the principal forms of generalised bone disease and outlined the
methods Frost has advocated in their assessment.
After Session 1, Professor J. J. Pritchard (Q.U.B.) made the point that anatomi-
cally bones were simple things but they had become "mixed up" with a major
portion of the body's metabolic activity and this helped to explain the variety of
disorders affecting the skeleton. Professor Pritchard asked how bones bent in
osteomalacia/rickets and Professor Dent in reply stated that in children the bending
of the femora occurred at the growing ends but that deformity of the femoral neck
could occur at the site of a Looser fracture.
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OCSESSION 2
A. PAGET'S DISEASE OF BONE
DR. V. PARSONS, M.D., F.R.CP. (Loud),
Physician; King's College Hospital, London
James Paget's disease of bone is a widespread disease which can affect all of the
bones in the body with many features of a diffuse abnormality, not only of bone
formation and modelling, but also affecting other connective tissue including the
vascular supply to the bone and finer vessels, angioid streaks in the eye.
There is evidence for a familial and geographical incidence of the disease which
suggests that it may be of genetic origin and there is evidence that it may be assoc-
iated with other diseases such as pseudoxanthoma elasticum and possibly thyroid-
itis.
The presenting symptoms and signs are extremely varied, but patients may
present to the orthopaedic surgeons and rheumatologists with arthritis, fractures and
sarcoma, to the neurologist with cranial nerve lesions, cervical cord lesions and
more rarely mid-brain and cerebral dysfunction, to the cardiologist with heart
failure and heart block, to the dental surgeon with difficulties associated with the
jaw and dentition and to the metabolic physician because of the derangements found
in calcium metabolism when those patients are admitted for other reasons. A pro-
portion of patients are asymptomatic and the disease is brought to light during
routine X-rays and biochemical investigations. These latter show characteristic
changes in alkaline and acid phosphatases and total urinary hydroxyproline. The
radiological, histological and bone scan features are typical.
The clinical picture is occasionally confused by other diseases occurring with
Paget's disease, such as carcinoma of the prostate, multiple myelomatosis, osteo-
malacia, sarcoidosis, all of which need to be disentangled in the particular patient.
Treatment involves a full assessment of the patients symptoms. How much of the
pain is due to degenerative arthritis? The extent of deformity and periosteal dis-
tension, fracture, increased bone blood flow, diversion of blood from muscle to
bone, and finally, malignant change. The range of treatment involved include local
radiotherapy, antimitotic agents such as mithramycin, diphosphonates and cal-
citonin (porcine, salmon and human).
B. MINERAL METABOLISM IN RHEUMATOID ARTHRITIS
Professor W. W. BUCHANAN, M.D., F.R.C.P. (Glasgow), F.R.CP. (Edin.)
The Centre for Rheumatic Diseases, Glasgow
It has been recognised for many years that one of the earliest radiological
features of rheumatoid arthritis is juxta-articular osteoporosis. However, the patho-
genesis of this and generalised osteoporosis has not been explained.
This paper described studies of osteoporosis in a large group of patients with
135rheumatoid arthritis, employing three radiological indices-metacarpal, femoral and
clavicular. The results show that a significant degree of osteoporosis occurred in
both males and females. Osteoporosis was particularly marked in those over 45
years of age, those with arthritis of long duration, and those who had been treated
with corticosteroid therapy. Of particular interest was the fact that osteoporosis
occurred to the same degree in bones close to joint inflammation e.g. the meta-
carpal, and those some distance from inflammed joints e.g. mid-point of femur.
Studies on the role of zinc in osteoporosis in rheumatoid arthritis were also de-
scribed. The plasma zinc has been found to be low in patients with the disease,
especially those treated with corticosteroid therapy, and the plasma zinc concen-
tration correlated with the degree of osteoporosis.
Finally, the results of more recent studies of serum calcium, phosphorus,
alkaline phosphatase, albumin and chloride, were reported which suggest that
patients with rheumatoid arthritis have a significant increase in parathyroid activity.
Discussion on Dr. Parson's paper after Session 2, emphasised that Paget's disease
could be associated with vitamin D deficiency.
SESSION 3
A. CLINICAL ASPECrS OF VITAMIN D METABOLISM
Dr. T. Mx CHALMERS, M.D., F.R.CP. (Lond4), F.R.C.P. (Edin.)
Consulant Physician, United Cambridge Hospitals
with
M. W. DAVIE, J. 0. HUNTER, E. KODICEK, I). E. M. LAWSON,
B. PELC and R. SPENCER
Addenbrooke's Hospital, Dunn and Strangeways Laboratories, Cambridge
In Europe vitamin D deficiency is common amongst patients with epilepsy. It
was suggested that this was a consequence of hepatic enzyme induction produced
by anticonvulsant drugs, which might increase the rate of breakdown of the vitamin.
We found, however, that the clearance of radioactive cholecalciferol from the
plasma was no faster in epileptics than in controls taking no drugs whatsoever,
and a further investigation revealed that the major factor controlling the rate of
cholecalciferol clearance was the plasma concentration of 25-hydroxyvitamin D.
Nevertheless, studies before and after treatment with ultra-violet light in normal
and epileptic subjects demonstrated that at any given concentration of 25-hydroxy-
vitamin D the rate of clearance of cholecalciferol was significantly faster in epilep-
tics, which strongly supports the suggestion that enzyme induction is important in
the pathogenesis of anticonvulsant osteomalacia.
In chronic renal failure resistance to vitamin D and osteodystrophy are thought
to be due to impaired production of the renal hormone, 1,25-dihydroxyvitamin D.
As a substitute for the honnone itself, which although therapeutically active is
136difficult to prepare, we have synthesised the analogue 1-alpha-hydroxycholecal-
ciferol. In four patients with renal osteodystrophy the administration of this sub-
stance, in an oral dose of 1.5-2Mug daily, has raised calcium absorption, lowered
serum parathyroid hormone concentration and produced radiological evidence of
bone healing.
In the discussion Dr. V. Parsons suggested that anticonvulsants might have an
effect on calcium transport across intestinal epithelium. Dr. Chalmers agreed with
this.
B. HARD TISSUE MINERALIZATION
DAME JANET VAUGHAN, D.BE.E, D;M., F.RCJP. (Lon4.)
formerly Hom Director, MRC Group for Research on Bone Seeking Isotopes,
Oxford
The question of how initial crystal formation occurs in mineralised tissue has
long exercised bone physiologists since it is agreed that the concentrations of
calcium and phosphate in blood are lower than those required to form new crystals
in vitro, though they are sufficient to allow precipitation of calcium phosphate onto
crystals already formed. It was originally suggested by Glimcher and his colleagues
that the collagen fibres in inorganic matrix might provide heterogenous nucleating
sites. Recent experimental evidence suggests that orientation of calcium phosphate
concentrates along the axis of collagen fibres is probably only secondary to the
formation of such concentrates in non-collagenous matrix. It appears probable that
certain cells of bone, cartilage and dentin may, through vesicle formation, enable
sufficient concentration of calcium and phosphate to occur in microscopic sites in
matrix to act as nucleation centres. The character of these vesicles and the possible
part played by the unique character of the glycoproteins present in relatively high
concentration in osteoid as compared to calcified bone and of pyrophosphate and
phosphatases were discussed. The possible influence of vitamin D metabolites and
parathyroid hormone on matrix mineralization were also briefly considered.
In discussion of Dame Janet's paper the epitaxic theory of calcification was
emphasised and it was suggested that this theory was more useful in examples of
ectopic calcification. The more active role ascribed to the osteoblast by Dame
Janet did not invalidate the theory of epitaxy since once microcrystals were formed
then presumably they combined with the collagenous component of the osteoid.
RECENT ADVANCES IN THE STUDY OF ViTAmiN D
H. F. DeLUCA
Steenbock Research Professor and Chairman Department of Biochemistry,
University of Wisconsin, Madison, Wsconsin, USA.
THE SIR THOMAS AND LADY EDITH DIXON LECTURE
It is well established that Vitamin D3 must be hydroxylated on C-25 in the liver
and subsequently on C-1 in the kidney to form 1,25-(OH),2D3 before it can function
137at physiological doses. Without apparent further metabolism, the 1,25-(OH)2D3
stimulates the intestine to transport calcium and phosphate, the mobilization of
calcium and phosphate from bone and the reabsorption of calcium in the kidney.
In true endocrine fashion, the biogenesis of 1,25-(OH)2D3 in the kidney is feed-back
regulated by 1,25-(OH)2D3 itself, by serum calcium concentration through the
parathyroid hormone and by serum inorganic phosphorus. Although the cellular and
molecular mechanisms of this regulation are not known at present, it is clear that
the physiologic need for calcium and for phosphorous as revealed by low serum
levels of these ions results in stimulation of 1,2540H)2D3 synthesis which then
mobilizes these ions from intestine and bone. The level of 1,25-(OH)I2D3 also plays a
regulatory role which may be permissive in nature. In the absence of 1,25-(OH)2D3,
the parathyroid hormone and inorganic phosphate of the serum do not regulate the
25-OH-D3-hydroxylase activity of kidney which is very high in the vitamin D-
deficient state regardless of the serum levels of Ca=, P04=and parathyroid
hormone.
Hypoparathyroid patients probably produce little 1,25-(OH)2D3 in response to
hypocalcemia and are easily treated with 1 ,ug/day of 1,25-(OH)2D3 plus 1 gram of
dietary calcium. Renal failure patients who probably lack the ability to synthesise
1,25-(0H),D3 are also markedly improved by treatment with 1,25-(OH).,D3 (Iug
3 times per week),. Vitamin D dependency rickets is also treated with 1,25-(OH)2D3
(1 jug/day) successfully. In all such treatments a synthetic analog of 1,25-(OH)2D3,
namely 1-alpha-OH-D3, is also effective, but the successful treatment level is about
twice that of 1,25-(OI),2D,. Additional clinical applications of the metabolites of
vitamin D3 were discussed.
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